CryoLife Current Valuation vs. Cash Per Share
| CYL Stock | EUR 26.60 1.00 3.91% |
For CryoLife profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CryoLife to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CryoLife utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CryoLife's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CryoLife over time as well as its relative position and ranking within its peers.
CryoLife |
CryoLife Cash Per Share vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CryoLife's current stock value. Our valuation model uses many indicators to compare CryoLife value to that of its competitors to determine the firm's financial worth. CryoLife is rated second in current valuation category among its peers. It is number one stock in cash per share category among its peers . The ratio of Current Valuation to Cash Per Share for CryoLife is about 737,761,803 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CryoLife's earnings, one of the primary drivers of an investment's value.CryoLife Current Valuation vs. Competition
CryoLife is rated second in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is currently estimated at about (580.86 Billion). CryoLife adds roughly 796.78 Million in current valuation claiming only tiny portion of all equities under Medical Devices industry.
CryoLife Cash Per Share vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CryoLife |
| = | 796.78 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
CryoLife |
| = | 1.08 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CryoLife Cash Per Share Comparison
CryoLife is currently under evaluation in cash per share category among its peers.
CryoLife Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CryoLife, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CryoLife will eventually generate negative long term returns. The profitability progress is the general direction of CryoLife's change in net profit over the period of time. It can combine multiple indicators of CryoLife, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people.
CryoLife Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CryoLife. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CryoLife position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CryoLife's important profitability drivers and their relationship over time.
Use CryoLife in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CryoLife position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CryoLife will appreciate offsetting losses from the drop in the long position's value.CryoLife Pair Trading
CryoLife Pair Trading Analysis
The ability to find closely correlated positions to CryoLife could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CryoLife when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CryoLife - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CryoLife to buy it.
The correlation of CryoLife is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CryoLife moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CryoLife moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CryoLife can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CryoLife position
In addition to having CryoLife in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Debt ETFs Thematic Idea Now
Broad Debt ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Debt ETFs theme has 229 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Debt ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in CryoLife Stock
To fully project CryoLife's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CryoLife at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CryoLife's income statement, its balance sheet, and the statement of cash flows.